About this episode
In this episode, JJ explores the rapidly growing research on psychedelic-assisted therapy and microdosing — and how these natural medicines are helping people heal from PTSD, anxiety, depression, and addiction when traditional methods fall short. She interviews AC Braddock , CEO of Eden Labs. http://edenlabs.com You'll learn:?What recent clinical trials at Johns Hopkins, NYU, and Harvard are revealing about psilocybin and MDMA? Why psychedelics are showing success rates of 60–80% for conditions once considered "treatment-resistant"? How microdosing differs from full-dose journeys and why it may gently rewire neural pathways for emotional regulation and resilience
